Dr Natalie Kenny

Dr. Natalie Kenny currently serves as the CEO and Managing Director of BioGrad, a position held since September 2014. Previously, Dr. Kenny worked as a Senior Scientist at Charles River Laboratories from October 2014 to August 2015 and held a fellowship in nanotoxicology at the Institute of Environment and Health from January 2013 to September 2014. Dr. Kenny's academic background includes a PhD in Translational Medicine from Cranfield University, completed in 2013, and graduate studies at the London School of Hygiene and Tropical Medicine. Earlier roles include Scientist Supervisor at Pfizer and various research positions, including Graduate Researcher at St George's Medical School and Graduate Research Assistant at The Johns Hopkins University.